The Global Oral Film Dissolving Agent Market was valued at USD 2.5 Billion in 2024 and is projected to reach USD 6.8 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period (2025–2032). This growth is being driven by rising demand for patient-friendly drug delivery systems, increasing prevalence of chronic disorders in geriatric and pediatric populations, and the accelerating adoption of advanced polymer-based dissolving technologies across pharmaceutical and nutraceutical sectors.

As the pharmaceutical industry transforms toward patient-centric formulations and enhanced bioavailability solutions, the spotlight is on the key manufacturers who are driving innovation, formulation efficiency, and accessible delivery pathways. In this blog, we profile the Top 10 Companies in the Oral Film Dissolving Agent Industry—a mix of biotech pioneers, polymer specialists, and contract developers shaping the future of global oral thin film technologies.

---

🔟 1. Cure Pharmaceutical

Headquarters: Oxnard, California, USA
Key Offering: CureFilm™ platform, custom oral dissolving films, sublingual agents

Cure Pharmaceutical stands out as a leader in nano-formulated oral thin films, leveraging its proprietary CureFilm platform to deliver therapeutics with enhanced absorption. The company focuses on treatments for pain management and CNS disorders, serving pharmaceutical partners with scalable film production for both Rx and OTC applications. Their technology emphasizes quick dissolution under 30 seconds, making it ideal for patients with dysphagia.

Innovation Initiatives:

• Nanoencapsulation for poor solubility drugs

• Partnerships for pediatric and geriatric formulations

• Expansion into nutraceutical delivery systems

Download FREE Sample Report: Oral Film Dissolving Agent Market – View in Detailed Research Report

---

9️⃣ 2. Adhex Pharma

Headquarters: Beynost, France
Key Offering: AdhexPharma® films, buccal and sublingual dissolving agents

Adhex Pharma excels in developing mucoadhesive oral films for personalized medicine, with a strong emphasis on European markets. Their portfolio includes agents for hormone replacement and antiemetics, produced via solvent casting for uniform drug release. The company collaborates with big pharma to integrate films into existing pipelines.

Innovation Initiatives:

• Mucoadhesive polymer blends for sustained release

• Customizable films for clinical trials

---

8️⃣ 3. Lubrizol Life Science

Headquarters: Cleveland, Ohio, USA
Key Offering: Alden™ polymers, film-forming excipients for ODTFs

Lubrizol Life Science provides advanced excipients like hydroxypropyl methylcellulose variants tailored for oral dissolving films. Their solutions support high drug loads and rapid disintegration, widely used in migraine and nausea treatments. With global manufacturing, they enable partners to meet FDA standards efficiently.

Innovation Initiatives:

• Bio-based polymers for sustainable films

• Excipient systems for 15-second dissolution

---

7️⃣ 4. CL Pharm

Headquarters: Seoul, South Korea
Key Offering: Clonazepam ODT films, generic oral dissolving agents

CL Pharm is a key Asian player specializing in generic oral thin films for epilepsy and anxiety, with production scaled for export. Their agents use pullulan and starch derivatives for superior mouthfeel and compliance, particularly in hospital settings across APAC.

Innovation Initiatives:

• High-volume generic film production

• Asia-focused regulatory approvals

Download FREE Sample Report: Oral Film Dissolving Agent Market – View in Detailed Research Report

---

6️⃣ 5. Shilpa Therapeutics

Headquarters: Raichur, India
Key Offering: Oral thin films for analgesics, pediatric agents

Shilpa Therapeutics leverages India’s manufacturing prowess to produce cost-effective dissolving agents for emerging markets. Focused on generics and biosimilars, they supply films for pain and GI disorders, emphasizing affordability and rapid scalability to meet rising demand in pharmacies.

Innovation Initiatives:

• Cost-optimized polymer formulations

• Expansion into veterinary thin films

---

5️⃣ 6. ZIM Laboratories

Headquarters: Nagpur, India
Key Offering: ZIM-I-Film™, nutraceutical dissolving strips

ZIM Laboratories pioneers multifunctional oral films combining pharma and nutraceuticals, with agents enabling vitamin and herbal delivery. Their platform supports OTC growth, with strong presence in self-medication trends across India and exports to Europe.

Innovation Initiatives:

• Nutraceutical-infused rapid-dissolve agents

• Target: Triple production capacity by 2026

---

4️⃣ 7. Tapemark

Headquarters: West St. Paul, Minnesota, USA
Key Offering: Contract film manufacturing, custom dissolving polymers

Tapemark serves as a CDMO leader, providing turnkey solutions for buccal and sublingual films used in opioid alternatives and allergy meds. Their expertise in hot-melt extrusion ensures high-quality agents for complex APIs.

Innovation Initiatives:

• Hot-melt processes for heat-sensitive drugs

• R&D partnerships for CNS applications

---

3️⃣ 8. IntelGenx

Headquarters: Montreal, Quebec, Canada
Key Offering: VersaFilm™, sublingual and buccal dissolving agents

IntelGenx leads with its VersaFilm technology for CNS and pain therapies, including FDA-approved products like Rizen for allergies. They focus on controlled release agents compatible with existing infrastructure.

Innovation Initiatives:

• VersaFilm for fast-onset CNS drugs

• Ongoing FDA filings for new indications

---

2️⃣ 9. BioDelivery Sciences (BDSI)

Headquarters: Raleigh, North Carolina, USA
Key Offering: BEMA® technology, opioid and pain management films

BioDelivery Sciences dominates with its BioErodible MucoAdhesive (BEMA) films for chronic pain, approved for buprenorphine delivery. Their agents prioritize bioavailability, serving hospitals and retail pharmacies.

Innovation Initiatives:

• BEMA for abuse-deterrent formulations

• Pain management pipeline expansion

---

1️⃣ 10. Aquestive Therapeutics

Headquarters: Warren, New Jersey, USA
Key Offering: PharmFilm®, anaphylaxis and migraine dissolving films

Aquestive Therapeutics tops the list with PharmFilm platform, powering FDA-approved Libervant for seizures and Anaphylm for emergencies. They lead in pediatric and allergy applications, with global partnerships driving adoption.

Innovation Initiatives:

• PharmFilm for needle-free epinephrine

• Strategic alliances with big pharma

Read Full Report: Oral Film Dissolving Agent Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Oral Film Dissolving Agent Is Faster, Smarter, and More Accessible

The oral film dissolving agent market is undergoing a dynamic shift. While traditional tablets still hold volume share, the industry is investing heavily in advanced polymer excipients, nanotechnology integration, and scalable manufacturing to meet demands for patient compliance and rapid action.

📈 Key Trends Shaping the Market:

• Rapid expansion of ODTF capacity in North America, Europe, and Asia-Pacific

• Regulatory fast-tracks for pediatric and geriatric formulations by 2030

• Digital tools for personalized film design and supply chain tracking

• Pharma-CDMO alliances accelerating OTC and nutraceutical launches

Read Full Report: Oral Film Dissolving Agent Market – View in Detailed Research Report

The companies listed above are not only formulating next-gen drug delivery—they’re spearheading the patient compliance revolution in pharmacotherapy.